You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study
|
---|---|
Published in |
Rheumatology Advances in Practice, October 2018
|
DOI | 10.1093/rap/rky042 |
Pubmed ID | |
Authors |
Gavin Clunie, Iain B McInnes, Nick Barkham, Helena Marzo-Ortega, Yusuf Patel, Andrew Gough, Jon Packham, Stuart Kyle, Bruce Kirkham, Tom Sheeran, Helen Coope, Anna Bishop-Bailey, Neil McHugh |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 60% |
Mexico | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Science communicators (journalists, bloggers, editors) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 3 | 16% |
Researcher | 3 | 16% |
Student > Doctoral Student | 2 | 11% |
Student > Bachelor | 1 | 5% |
Lecturer | 1 | 5% |
Other | 2 | 11% |
Unknown | 7 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 26% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 11% |
Biochemistry, Genetics and Molecular Biology | 2 | 11% |
Mathematics | 1 | 5% |
Economics, Econometrics and Finance | 1 | 5% |
Other | 1 | 5% |
Unknown | 7 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2021.
All research outputs
#2,136,516
of 23,318,744 outputs
Outputs from Rheumatology Advances in Practice
#57
of 346 outputs
Outputs of similar age
#47,198
of 349,304 outputs
Outputs of similar age from Rheumatology Advances in Practice
#3
of 24 outputs
Altmetric has tracked 23,318,744 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 346 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,304 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.